These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6541452)

  • 1. Single-dose pharmacokinetics of aztreonam in pediatric patients.
    Stutman HR; Marks MI; Swabb EA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges.
    Duma RJ; Berry AJ; Smith SM; Baggett JW; Swabb EA; Platt TB
    Antimicrob Agents Chemother; 1984 Nov; 26(5):730-3. PubMed ID: 6542765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of single- and multiple-dose pharmacokinetics of the monobactam, aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA
    Chemotherapy; 1983; 29(5):313-21. PubMed ID: 6684541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R; Hashira S; Tajima T; Meguro H; Abe T; Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M
    Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the clinical pharmacology of the monobactam antibiotic aztreonam.
    Swabb EA
    Am J Med; 1985 Feb; 78(2A):11-8. PubMed ID: 3881946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue penetration of azthreonam.
    Wise R; Dyas A; Hegarty A; Andrews JM
    Antimicrob Agents Chemother; 1982 Dec; 22(6):969-71. PubMed ID: 6891575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; McKinstry DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):125-32. PubMed ID: 6681947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam in human serum and breast milk.
    Fleiss PM; Richwald GA; Gordon J; Stern M; Frantz M; Devlin RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):509-11. PubMed ID: 4039600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of aztreonam in cancer patients.
    Jones PG; Bodey GP; Swabb EA; Ho DH; Fainstein V; Pasternak J
    Antimicrob Agents Chemother; 1984 Oct; 26(4):455-61. PubMed ID: 6542763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of aztreonam in rabbit eyes.
    Barza M; McCue M
    Antimicrob Agents Chemother; 1983 Oct; 24(4):468-73. PubMed ID: 6685992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of aztreonam. An update.
    Mattie H
    Clin Pharmacokinet; 1994 Feb; 26(2):99-106. PubMed ID: 8162661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.